You're sitting in a consultation room, looking at two treatment options that seem to promise the same result: smoother forehead lines, a softer frown, and a more rested expression. One person tells you Dysport works faster. Another swears by Botox. The price per unit looks different, and the marketing makes the choice feel like a rivalry.
The more useful question isn't which is better, Botox or Dysport. It's which product suits your treatment area, muscle strength, facial anatomy, timing, and previous response. Both are legitimate botulinum toxin type A treatments, but the best choice can change from the forehead to the glabella, from crow's feet to the masseter.
| Criterion | Botox, onabotulinumtoxinA | Dysport, abobotulinumtoxinA |
|---|---|---|
| Active ingredient | OnabotulinumtoxinA | AbobotulinumtoxinA |
| Typical practical strength | More localized control | Broader spread in some treatment patterns |
| Onset | Often gradual, with full effects developing over several days | Often noticed earlier in comparative studies |
| Duration | Commonly comparable to Dysport | Commonly comparable to Botox |
| Unit dosing | Units are product-specific | Units are product-specific and not interchangeable |
| Often considered for | Precision areas and controlled placement | Broader muscles and wider treatment patterns |
Table of Contents
- Why Patients Ask Which Is Better Botox or Dysport
- How Botox and Dysport Actually Work
- Side-by-Side Comparison of Botox and Dysport
- Choosing by Treatment Area and Anatomy
- Safety, Eligibility, and Switching Considerations
- When Dysport Wins and When Botox Wins
- Your Decision Framework and Next Step at ProMD Health
Why Patients Ask Which Is Better Botox or Dysport
A patient once arrived for a consultation with the question already framed as a contest. She wanted to soften her frown lines before an upcoming event and had heard that Dysport was faster, but her sister had used Botox for years and trusted the name. She wasn't asking for a marketing opinion. She wanted to know whether choosing the “wrong” vial would leave her with an unnatural result.
That concern is reasonable. Botox Cosmetic received FDA approval for glabellar lines in 2002, following earlier medical approvals between 1989 and 1991, while Dysport received FDA approval for glabellar lines in 2009. In the United States, Botox therefore entered the aesthetic market about seven years earlier, giving it a longer history of post-marketing use and comparative study in major markets. You can review the product history and labeling in this Botox Cosmetic overview.
Both products are derived from botulinum toxin type A, and both temporarily reduce muscle activity that contributes to dynamic wrinkles. That overlap makes a simple winner sound plausible. In practice, the outcome depends on the injection site, muscle mass, skin thickness, dose, placement, dilution, and the injector's ability to read movement before placing the needle.
The patient's anatomy matters more than the label
Marketing often highlights one product's onset or another product's familiarity. Those details matter, but they don't determine the result by themselves. A broad, powerful frontalis may respond well to a product that distributes across the muscle. A patient with low brows may need tighter control to avoid unwanted heaviness.
The same product can be an excellent choice in one area and a poor choice in another. A thoughtful injector doesn't begin with brand loyalty. They begin by watching how the patient raises the brows, frowns, smiles, squints, and clenches.
Practical rule: Choose the product and dose for the muscle pattern in front of you, not for the reputation attached to the vial.
Clinical evidence also resists a universal verdict. In a randomized study of 91 patients with blepharospasm or hemifacial spasm, a 4:1 Dysport-to-Botox conversion ratio produced similar efficacy and tolerability, while duration and booster needs differed between the groups. A separate randomized crossover study of 54 patients with cervical dystonia found better impairment and pain scores with Dysport at particular conversion factors, but also more adverse events, including dysphagia. Those findings show why “better” changes with the indication and endpoint, as documented in this comparative clinical review.
How Botox and Dysport Actually Work
Botox and Dysport reduce dynamic wrinkles by interrupting communication between a nerve and the muscle it activates. After injection into a selected muscle, botulinum toxin type A affects the nerve ending and temporarily reduces acetylcholine release at the neuromuscular junction. The muscle then contracts less forcefully, allowing the overlying skin to look smoother.
The result isn't permanent paralysis. Nerve signaling gradually returns, and muscle movement comes back over time. That temporary effect is why treatment requires maintenance and why the injector must preserve enough movement to keep the face expressive.
Same toxin family, different products
Botox contains onabotulinumtoxinA, while Dysport contains abobotulinumtoxinA. Both were developed as botulinum toxin type A injectables, but their formulations and product characteristics differ. Those differences can influence how the product distributes through tissue, how many units are used, and how an experienced injector plans placement.
The regulatory timeline also helps explain the difference in familiarity. Botox Cosmetic was approved for glabellar lines in 2002, while Dysport followed in 2009, as described in the FDA product labeling for Dysport. Botox's earlier aesthetic entry doesn't make it automatically more effective. It does give clinicians and patients a longer period of accumulated use and recognition.
For a patient-friendly explanation of the treatment mechanism, see how Botox works for wrinkles.
Units cannot be swapped between brands
The most important dosing point is easy to miss: Botox and Dysport units are not interchangeable. A Dysport unit isn't the same measurement as a Botox unit, and the number written on a treatment plan must be interpreted within that product's own potency system.
The Dysport prescribing information states that its potency units are specific to the preparation and assay method and cannot be compared directly with or converted into units of another botulinum toxin product. That is why a larger number of Dysport units doesn't mean Dysport is weaker, and a smaller Botox number doesn't mean Botox is stronger. The Dysport prescribing information is the appropriate reference for this distinction.
A conversion ratio may be studied for a specific indication, but no single ratio works across every area. The dose must match the muscle, the goal, and the product being used.
Side-by-Side Comparison of Botox and Dysport
Patients usually want five practical answers: how quickly the result appears, how long it lasts, how far it spreads, how many units are needed, and what the appointment costs. The first three have been studied comparatively, but the findings don't support a fixed promise for every face.
Dysport is often associated with earlier visible change and broader distribution. In comparative frontalis data, measurable onset within 18 hours was reported in 90% of frontalis sides treated with abobotulinumtoxinA versus 20% treated with onabotulinumtoxinA. A separate glabellar-line study also reported significantly earlier onset for abobotulinumtoxinA at the same 2.5:1 unit ratio. These findings come from the review of comparative botulinum toxin studies, and they shouldn't be treated as a guarantee for an individual appointment.
| Criterion | Botox, onabotulinumtoxinA | Dysport, abobotulinumtoxinA |
|---|---|---|
| Onset | Full effects commonly develop over several days; timing varies by patient and area | A median onset of about one week appears in prescribing information, while comparative studies often report earlier visible change |
| Duration | In a frontalis study, median complete efficacy was 56 days at the studied ratio | In the same type of comparison, median complete efficacy was 72 days |
| Broader duration finding | Duration varies with area, dose, muscle activity, and technique | Independent reviews most often report onset within 2 to 3 days and duration around four months |
| Spread | More localized behavior can help with precise placement | Broader spread can help cover wide muscles, but may be undesirable near sensitive structures |
| Units | Product-specific and not interchangeable | Product-specific and not interchangeable |
| Cost | Per-unit pricing can look higher, but the total depends on units and the treatment plan | Per-unit pricing can look lower, but the total depends on the higher product-specific unit count |
| Best interpretation | Useful when millimeter-level control is the priority | Useful when coverage and earlier visible change are important |
Duration is not a brand-only decision
A frontalis comparison reported median complete efficacy of 72 days for abobotulinumtoxinA versus 56 days for onabotulinumtoxinA, with full efficacy reported at 103 days versus 87 days, respectively, at a 2.5:1 dose ratio. Those are study-specific results, not a promise that every Dysport treatment lasts longer. A broader review concluded that both products can provide comparable safety and efficacy across many indications, with outcomes shaped by indication, injection pattern, and non-equivalent labeling, as discussed in this comparative duration review.
Cost deserves the same caution. Dysport may have a lower price per unit, but it generally requires a different unit count. Comparing unit prices without comparing the full treatment plan is one of the least useful ways to judge value. Ask for the total price, the treated areas, the planned units, and the maintenance expectations.
For a practical overview of treatment longevity, ProMD Health Columbia's guide explains how long Botox lasts.
Choosing by Treatment Area and Anatomy
A trained injector chooses a neuromodulator by watching the muscle pattern, not by selecting a favorite brand in advance. The same patient may benefit from different products in different areas because each muscle has a different size, direction of pull, and relationship to nearby structures.
Start with the muscle, not the wrinkle
The glabella is the area between the eyebrows where the corrugator and procerus muscles create frown lines. Dysport's broader distribution may soften this pattern efficiently, but broader spread isn't always helpful. A patient with low brows or heavy upper lids may need tighter control around structures that influence brow and eyelid position, making Botox a more conservative choice.
The forehead involves the frontalis, a broad muscle that lifts the brows. Dysport can be useful when the muscle is thick, active, and producing lines across a wide surface. Botox may be preferable in a tall, narrow forehead or when the injector needs precise control to preserve a balanced brow position.
Crow's feet involve the lateral orbicularis oculi. Either product can work well, but the desired finish matters. A softly feathered treatment may blend naturally during a smile, while more localized placement can suit someone who wants careful control for close-up photography.
The product doesn't create a natural result on its own. Placement, dose, and preservation of appropriate movement do.
Match spread to the treatment goal
Bunny lines and a lip flip require precision because small dose or placement changes can affect expression and function. Botox often makes sense when the goal is tightly controlled treatment near the nose or lips. Masseter treatment for bruxism or jawline slimming is different. The masseter is a thick, broad muscle, so Dysport's tendency toward wider distribution may be useful when the plan calls for coverage through a larger muscle.
| Treatment area | Preferred product | Reason |
|---|---|---|
| Glabella | Botox when precision is especially important | More localized control may help in patients with low brows or heavy lids |
| Broad forehead | Dysport in suitable muscle patterns | Wider distribution may help cover an active, broad frontalis |
| Narrow or tall forehead | Botox may be preferred | More controlled placement can support careful brow balance |
| Crow's feet | Either, based on expression goals | The injector can choose between feathered coverage and tighter control |
| Bunny lines | Botox often suits the goal | Small muscles and nearby structures demand precision |
| Lip flip | Botox often suits the goal | Controlled dosing helps preserve lip function and smile dynamics |
| Masseters | Dysport may be useful | A broad muscle can benefit from coverage through a larger treatment field |
This anatomy-first approach also protects against over-treating. A product that spreads well through one muscle can drift farther than desired in another. The safest plan accounts for muscle depth, contraction strength, brow position, eyelid anatomy, and the amount of movement the patient wants to retain.
Safety, Eligibility, and Switching Considerations
Botox isn't automatically safer than Dysport, and Dysport isn't automatically safer than Botox. Both require medical screening, accurate product handling, and injection by a qualified professional who understands facial anatomy.
A consultation should identify allergies, previous reactions, medications, pregnancy or breastfeeding, neuromuscular conditions, and any infection near the planned injection sites. Dysport's prescribing information states that patients shouldn't receive it if they're allergic to cow's milk protein, have had an allergic reaction to Botox, or are pregnant or breastfeeding. Its official information also describes approval for temporary improvement of glabellar lines in adults under 65 years, as detailed in the Dysport healthcare professional information.
Eligibility comes before product preference
Treatment should be postponed when there's an active infection at the injection site. Known hypersensitivity to a product or one of its components also matters. People with certain neuromuscular disorders require careful medical review, because botulinum toxin can affect neuromuscular transmission beyond the cosmetic target.
Medication history is equally important. Some drugs can alter neuromuscular function or increase bruising risk, so patients should provide a complete list rather than mentioning only prescription medications. Don't stop a prescribed medication on your own. The injector can explain whether treatment should be delayed or whether the prescribing clinician needs to be involved.
Switching doesn't solve every poor result
A disappointing response to Botox or Dysport often reflects dose, placement, dilution, muscle strength, or an inaccurate assessment of the movement pattern. Switching products without identifying the cause can reproduce the same problem with a different label.
A patient who wants to switch should bring prior treatment records when possible. The injector needs to know which product was used, which areas were treated, how many product-specific units were administered, when the treatment occurred, and what result followed. That information is more useful than a general statement that one product “didn't work.”
The two products also shouldn't be treated as interchangeable during a switch. A new plan should be calculated for the new product and the specific anatomy, not copied unit for unit from the previous treatment.
When Dysport Wins and When Botox Wins
Dysport can win when the treatment area is broad, the target muscle is strong, and earlier visible change matters. A thick frontalis with pronounced dynamic lines may benefit from a product that distributes across a wider field. The masseter presents a similar logic because it's a substantial muscle with a larger treatment surface.
Dysport's prescribing information reports a median onset of about one week, while independent aesthetic literature most often reports onset within 2 to 3 days and duration around four months. The evidence is not perfectly consistent, but the pattern explains why some patients prefer Dysport when they're working toward a near-term event. The independent review of abobotulinumtoxinA onset and duration also emphasizes that dilution, depth, injection pattern, and anatomy influence those observations.
When control matters more than coverage
Botox remains a strong default when the injector needs close control. That includes a glabella in a patient with heavy lids, a subtle lip flip, bunny lines, brow shaping, and areas near muscles that influence eyelid or smile position. A more localized treatment field can be helpful when a few millimeters make a meaningful difference.
Botox's longer history in aesthetic practice can also be reassuring for a first-time patient, particularly when the treatment plan depends on conservative dosing and careful observation. That isn't a claim that Botox works better for everyone. It's a practical reason some injectors begin with it when the anatomy is delicate or the patient has no prior response to guide the plan.
Dysport is often the coverage choice. Botox is often the control choice. Neither description replaces an examination.
The best decision may also change over time. If a patient responds well to one product and likes the timing, movement, and duration, that previous response becomes useful information. If the result is uneven or too heavy, the next visit should focus on what happened clinically before changing brands.
Your Decision Framework and Next Step at ProMD Health
Bring four questions to your consultation. They'll produce a more useful conversation than asking which brand is universally superior.
Where are you treating? Forehead, glabella, crow's feet, bunny lines, lips, and masseters have different anatomy. Broad muscles may favor broader distribution, while delicate areas may require tighter control.
How quickly do you need visible change? Dysport may show earlier visible effects in comparative studies, but individual onset varies. If the appointment is tied to an event, schedule with enough time for the injector to assess the finished result rather than choosing solely for a promised timeline.
Have you used either product before? Your prior response matters. Bring treatment records if you're switching, especially information about the product, treatment areas, units, timing, and how long the result lasted.
What's your budget per session? Per-unit prices can be misleading because Botox and Dysport use different unit systems. Compare the complete plan, including areas, product-specific units, follow-up, and maintenance timing.
What a useful consultation should establish
The injector should assess your resting anatomy and movement, then explain why a particular product fits the treatment area. You should leave with a clear dosing plan, realistic onset expectations, likely duration, aftercare guidance, and a plan for evaluating the result once the treatment has taken effect.
At ProMD Health Columbia, Botox and Dysport are available for consultation-based treatment planning, with the product choice matched to the patient's goals, anatomy, dose, placement, and maintenance needs. If you're considering Dysport in Columbia, you can review the clinic's Dysport treatment information before scheduling.
Don't choose based only on a lower per-unit price or a promise of faster results. Choose a qualified injector who can explain why the product fits your muscles and who will reassess the result rather than treating every face from the same template. A two-week follow-up is a practical time to evaluate the outcome and discuss any refinement.
Schedule a consultation with ProMD Health Columbia to compare Botox and Dysport for your specific treatment areas, including the forehead, glabella, crow's feet, or masseters. Bring your prior injection records if you're switching products, and ask for a personalized dosing plan and follow-up timeline.
